Type 2 Diabetes
Chronic high blood sugar from insulin resistance
What it is
Type 2 diabetes is a chronic condition of elevated blood glucose caused by insulin resistance combined with a relative shortfall in insulin secretion. It usually develops gradually, often preceded by years of prediabetes.
Why it matters
Sustained high glucose damages blood vessels and nerves, driving heart attack, stroke, kidney disease, vision loss, and neuropathy. Much of this risk is preventable with early detection and treatment of glucose, blood pressure, and lipids together.
What BioSignal knows about treating this
What works for Type 2 Diabetes
BioSignal’s clinical summary, most important first.
- Weight loss (lifestyle or medication)
- Physical activity for insulin sensitivity
- Dietary carbohydrate quality
- Metformin, GLP-1, and SGLT2 therapies (clinician-directed)
- Blood pressure and lipid control
Signal Records relevant to this condition
Interventions and contributing factors — some of these records describe a cause rather than a cure. The rating shown is BioSignal’s confidence in that Signal Record, not a claim about how well it treats this condition. Open any of them for the full evidence.
- Intermittent FastingModerate confidence
It works for weight loss — by helping you eat less, not by metabolic magic. Not superior to calorie restriction. Protect your muscle. Unsafe on insulin.
- MagnesiumModerate confidence
Genuinely effective for a few specific things — eclampsia (in hospital), constipation, migraine prevention, and a modest blood-pressure effect. The reasons most people actually buy it — sleep, cramps, anxiety — are the weakest part of the evidence.
New to this? Read these first
How this usually unfolds
- Recognize risk factors
- Get diagnosed
- Track key biomarkers
- Lifestyle first
- Evidence-based treatment
- Long-term monitoring
Who is at risk
- Overweight and obesity
- Family history
- Physical inactivity
- Prediabetes
- Older age
- Higher-risk ethnic background
- History of gestational diabetes or PCOS
How it's diagnosed
Diagnosis uses HbA1c ≥ 6.5%, fasting glucose ≥ 126 mg/dL, a 2-hour glucose tolerance test ≥ 200 mg/dL, or a random glucose ≥ 200 mg/dL with symptoms — confirmed on a second test unless clearly symptomatic.
Key biomarkers
Lifestyle
Explore this condition across BioSignal
Related Foundations
Related Signal Records
Related peptide families
Related body systems
Frequently asked questions
Can type 2 diabetes be reversed?
Substantial weight loss can push type 2 diabetes into remission for some people, especially early in the disease — though it can return if weight is regained. 'Remission' is a better word than 'cure.'
Which number matters most?
HbA1c tracks average glucose over months and guides most treatment decisions, but managing blood pressure and ApoB/LDL alongside it prevents the most complications.
Evidence summary
The benefits of glucose, blood-pressure, and lipid control in type 2 diabetes are established by large trials; GLP-1 and SGLT2 agents additionally reduce cardiovascular and kidney events in high-risk patients.
References & sources
- ADA Standards of Care in Diabetes
- Diabetes Prevention Program
- Cardiovascular- and kidney-outcome trials (GLP-1, SGLT2)
Educational information — not medical advice
Is this condition page clear, accurate, and useful? Your feedback shapes what we review next.
Give feedback